Table 1 Characteristics of ovarian carcinosarcoma cohort.
N | %/range | ||
|---|---|---|---|
Cases | Total | 82 | — |
Age | Median years | 69 | Range 47–83 |
FIGO stage at diagnosis | I | 9 | 11.4 |
II | 8 | 10.1 | |
III | 51 | 64.6 | |
IV | 11 | 13.9 | |
NA | 3 | — | |
Neoadjuvant | Yes | 4 | 4.9 |
No | 78 | 95.1 | |
First-line treatment | Platinum–taxane doublet | 26a | 31.7 |
Other platinum combinations | 2 | 2.4 | |
Single-agent platinum | 26 | 31.7 | |
Other chemotherapy | 5 | 6.1 | |
Surgery only | 23b | 28.0 | |
Debulking status | No visible RD | 30 | 38.0 |
Macroscopic RD <2 cm | 15 | 19.0 | |
Macroscopic RD ≥2 cm | 30 | 38.0 | |
Macroscopic RD NOS | 4 | 5.1 | |
Unknown | 3 | — | |
Diagnosis period | Pre-1990s | 7 | 8.5 |
1990–1999 | 25 | 30.5 | |
2000–2009 | 20 | 24.4 | |
2010 onwards | 30 | 36.6 | |
Disease status | Relapsed | 75 | 91.5 |
Stable at last follow-up | 7 | 8.5 | |
Vital status | Alive at last follow-up | 4 | 4.9 |
Deceased—ovarian cancer | 72 | 87.8 | |
Deceased—other causes | 6 | 7.3 | |
